Literature DB >> 34124892

Catalytic Enantioselective Synthesis of Pyridyl Sulfoximines.

Yu Tang1, Scott J Miller1.   

Abstract

With unique chemical and biological activity, sulfoximines have attracted enormous attention in the past decades, whereas limited reports exist for their synthesis via asymmetric catalysis. We report the synthesis of chiral sulfoximines through the desymmetrizing N-oxidation of pyridyl sulfoximines using an aspartic acid-containing peptide catalyst. Various mono- and bis-pyridyl sulfoximine oxides are obtained with up to 99:1 er. The directing group introduced on the substrate highly enhances the enantioinduction and could be easily removed to give the free N-H sulfoximines. Additionally, peptides with methyl ester and the methyl amide C-terminal protecting group give the opposite enantiomers of the product. A binding model is proposed to explain this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34124892      PMCID: PMC8262370          DOI: 10.1021/jacs.1c04431

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   16.383


  41 in total

1.  Aspartate-catalyzed asymmetric epoxidation reactions.

Authors:  Gorka Peris; Charles E Jakobsche; Scott J Miller
Journal:  J Am Chem Soc       Date:  2007-06-26       Impact factor: 15.419

2.  Catalytic enantioselective Minisci-type addition to heteroarenes.

Authors:  Rupert S J Proctor; Holly J Davis; Robert J Phipps
Journal:  Science       Date:  2018-04-05       Impact factor: 47.728

3.  Chemoselective and enantioselective oxidation of indoles employing aspartyl peptide catalysts.

Authors:  Filip Kolundzic; Mohammad N Noshi; Meiliana Tjandra; Mohammad Movassaghi; Scott J Miller
Journal:  J Am Chem Soc       Date:  2011-05-23       Impact factor: 15.419

4.  Rhodium-catalyzed imination of sulfoxides and sulfides: efficient preparation of N-unsubstituted sulfoximines and sulfilimines.

Authors:  Hiroaki Okamura; Carsten Bolm
Journal:  Org Lett       Date:  2004-04-15       Impact factor: 6.005

5.  Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry.

Authors:  Patrick Mäder; Lars Kattner
Journal:  J Med Chem       Date:  2020-09-23       Impact factor: 7.446

6.  Iron(II) triflate as an efficient catalyst for the imination of sulfoxides.

Authors:  Olga García Mancheño; Jonathan Dallimore; Andrew Plant; Carsten Bolm
Journal:  Org Lett       Date:  2009-06-04       Impact factor: 6.005

7.  Rhodium-catalyzed stereoselective amination of thioethers with N-mesyloxycarbamates: DMAP and bis(DMAP)CH(2)Cl(2) as key additives.

Authors:  Hélène Lebel; Henri Piras; Johan Bartholoméüs
Journal:  Angew Chem Int Ed Engl       Date:  2014-05-30       Impact factor: 15.336

8.  Iron-catalyzed imidative kinetic resolution of racemic sulfoxides.

Authors:  Jun Wang; Marcus Frings; Carsten Bolm
Journal:  Chemistry       Date:  2013-12-16       Impact factor: 5.236

9.  Aspartyl Oxidation Catalysts That Dial In Functional Group Selectivity, along with Regio- and Stereoselectivity.

Authors:  Joshua S Alford; Nadia C Abascal; Christopher R Shugrue; Sean M Colvin; David K Romney; Scott J Miller
Journal:  ACS Cent Sci       Date:  2016-09-13       Impact factor: 14.553

10.  Peptide-Based Catalysts Reach the Outer Sphere through Remote Desymmetrization and Atroposelectivity.

Authors:  Anthony J Metrano; Scott J Miller
Journal:  Acc Chem Res       Date:  2018-12-11       Impact factor: 22.384

View more
  2 in total

1.  Synthesis of chiral sulfinate esters by asymmetric condensation.

Authors:  Xin Zhang; Esther Cai Xia Ang; Ziqi Yang; Choon Wee Kee; Choon-Hong Tan
Journal:  Nature       Date:  2022-02-14       Impact factor: 69.504

2.  Accessing Perfluoroaryl Sulfonimidamides and Sulfoximines via Photogenerated Perfluoroaryl Nitrenes: Synthesis and Application as a Chiral Auxiliary.

Authors:  Giampiero Proietti; Julius Kuzmin; Azamat Z Temerdashev; Peter Dinér
Journal:  J Org Chem       Date:  2021-11-12       Impact factor: 4.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.